关键数据
1.350今开
1.640最高
12.49K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.10%换手率
1.360昨收
1.345最低
17.60K成交额
亏损市盈率静
-5.47市净率
0.00%股息率 TTM
-112.37%ROA
4.70352周最高
0.03量比
-20.78M净利润
12.76M总股本
-1.4460每股收益TTM
2.27Beta
-157.37%ROE
1.11052周最低
21.69%振幅
--毛利率
17.74M总市值
-1.69回报/风险
6.21%风险率

即将为您带来更多新闻,敬请期待。。。
分析师评级
买入评级
17.500目标均价
+1186.76%涨幅空间
Lantern Pharma Inc 最新财报电话会记录
Lantern Pharma (LTRN) 2026财年第二季度业绩电话会议:运营亏损收窄,LP-300与Open Medicine AI
Lantern Pharma 2026财年第二季度业绩电话会议:营业亏损收窄25%至350万美元,现金余额为740万美元,同时LP-300和Open Medicine AI取得进展。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
Lantern Pharma Inc 简介
Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 100 billion oncology-focused data points and a library of over 200+ advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. It has active clinical programs for its three lead small molecule drug candidates: LP-300, LP-184, and LP-284. These programs are focused on multiple cancer indications, including both solid tumors and blood cancers. It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.
行业生物技术与医疗研究
公司代码LTRN
员工数量24
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| Biological Mimetics, Inc | 7.47% |
|---|
| Bios Equity Partners, LP. | 7.38% |
|---|
| Prophase Labs Inc | 5.58% |
|---|
| Satterfield (Thomas A Jr) | 5.04% |
|---|
| 股东类型 | 占比 |
|---|
| Corporation | 13.05% |
|---|
| Investment Advisor | 7.58% |
|---|
| Venture Capital | 7.38% |
|---|
| Individual Investor | 5.45% |
|---|
常见问题
Lantern Pharma Inc(LTRN)的当前股价是多少?
Lantern Pharma Inc(LTRN)的当前股价是 1.36。
Lantern Pharma Inc的股票代码是什么?
Lantern Pharma Inc的股票代码是LTRN。
Lantern Pharma Inc股票的52周最高点是多少?
Lantern Pharma Inc股票的52周最高点是4.70。
Lantern Pharma Inc股票的52周最低点是多少?
Lantern Pharma Inc股票的52周最低点是1.11。
Lantern Pharma Inc的市值是多少?
Lantern Pharma Inc的市值是17.35M。
现在Lantern Pharma Inc(LTRN)的股票是买入、持有还是卖出?
根据分析师评级,Lantern Pharma Inc(LTRN)的总体评级为买入,目标价格为17.50。
Lantern Pharma Inc(LTRN)股票的每股收益(EPS TTM)是多少
Lantern Pharma Inc(LTRN)股票的每股收益(EPS TTM)是-1.45。